Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972138priorityCriticalpatent/ECSP972138A/en
Publication of ECSP972138ApublicationCriticalpatent/ECSP972138A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuestos de la fórmula I (gráfico), en donde R10 está representado por la fórmula (A), (b) o [c) (gráfico) , R20 está representado por la fórmula I: (U), (V) o (W) (gráfico), y los otros sustituyentes son como se ha definido en la descrpción; y sus sales farmacéuticamente aceptables, son inhibidores de prostaglandin G/H sintasa y son agentes antiflamatorios y analgésicos.Compounds of formula I (graph), where R10 is represented by formula (A), (b) or [c) (graph), R20 is represented by formula I: (U), (V) or (W ) (graph), and the other substituents are as defined in the description; and its pharmaceutically acceptable salts, are prostaglandin G / H synthase inhibitors and are anti-inflammatory and analgesic agents.
ECSP9721381997-05-291997-05-29
NEW DERIVATIVES OF PIRROL
ECSP972138A
(en)
NON-PEPTIDIC INHIBITING COMPOUNDS OF THE VLA-4 DEPENDENT CELL UNION IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES; PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE
USE OF TIADIAZOLO PYRIDINE DERIVATIVES FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MODULATED BY INHIBITION OF THE PHOSPHODIESTERASE (S)